Copyright
©The Author(s) 2005.
World J Gastroenterol. Jul 14, 2005; 11(26): 4052-4060
Published online Jul 14, 2005. doi: 10.3748/wjg.v11.i26.4052
Published online Jul 14, 2005. doi: 10.3748/wjg.v11.i26.4052
Figure 1 H&E-stained sections of rat gastric mucosa.
A, treatment with indomethacin 100 µmol/kg, A: severe lesion with necrosis of gastric mucosa; B: several polymorphonuclear cell scan be detected (arrows); C and D: Rats treated with lansoprazole 90 mmol/kg plus indomethacin 100 µmol/kg, C: less severe lesion with lysis of mucosal cells; D: few polymorphonuclear cells can be evidenced (arrows). A and C: original magnification 100; bar = 150 µm. B and D: original magnification 170 x; bar = 60 µm.
- Citation: Blandizzi C, Fornai M, Colucci R, Natale G, Lubrano V, Vassalle C, Antonioli L, Lazzeri G, Tacca MD. Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage. World J Gastroenterol 2005; 11(26): 4052-4060
- URL: https://www.wjgnet.com/1007-9327/full/v11/i26/4052.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i26.4052